M.K.A. Basra

Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people: systematic review and economic evaluation

The Global Burden of Skin Disease in 2010: An Analysis of the Prevalence and Impact of Skin Conditions

Intralesional triamcinolone for flares of hidradenitis suppurativa (HS): A case series

Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study

Psoriasis

Burden of skin diseases

TFOS DEWS II Management and Therapy Report

The assessment of dermatological needs in resource‐poor regions

Hidradenitis suppurativa

Psoriasis

The etiology, diagnosis, and management of hyperhidrosis: A comprehensive review

The Evolution of Quality of Life Assessment and Use in Dermatology

Psychometric properties of the Itch Numeric Rating Scale in patients with moderate‐to‐severe plaque psoriasis

Physiology of sweat gland function: The roles of sweating and sweat composition in human health

Psoriasis Pathogenesis and Treatment

Correlative imaging of ionic transport and electronic structure in nano Li_0.5FePO₄ electrodes

Interventions for rosacea

CAR T cell immunotherapy for human cancer

Apremilast for the treatment of moderate‐to‐severe palmoplantar psoriasis: results from a double‐blind, placebo‐controlled, randomized study

Efficacy and Safety of Topical Rapamycin in Patients With Facial Angiofibromas Secondary to Tuberous Sclerosis Complex

Therapeutic patient education and self‐management support for patients with psoriasis – a systematic review

Comparison of the impairment of family quality of life assessed by disease‐specific and dermatology‐specific instruments in children with atopic dermatitis

The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results

The Psoriasis Family Index: Preliminary Results of Validation of a Quality of Life Instrument for Family Members of Patients with Psoriasis

The family impact of skin diseases: the Greater Patient concept

The Role of the EQ-5D in the Economic Evaluation of Dermatological Conditions and Therapies

Determining the Minimal Clinically Important Difference and Responsiveness of the Dermatology Life Quality Index (DLQI): Further Data

The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease

Measurement of health‐related quality of life in dermatological research and practice: outcome of theEADVTaskforce on Quality of Life

Conceptualization, development and validation of T‐QoL^©(Teenagers’ Quality of Life): a patient‐focused measure to assess quality of life of adolescents with skin diseases

Clinical experience and psychometric properties of the Children's Dermatology Life Quality Index (CDLQI), 1995-2012